Leo Varadkar (Dublin West, Fine Gael) | Oireachtas source

I do not have a timeline for Senator Moloney but I will certainly check on it to see whether there is a timeline for it.

I conducted a quick research check before responding to the debate. Unfortunately, I have not been able to find a significant amount of research on it, although there is one paper which suggests that, while there is no statistically different improvement in HbA1c in outcomes in the sense that a port and a pump work equally well, the use of a port is less expensive. The small bit of research that I managed to find seems to suggest that it would be cost effective but, as I stated, it would be inappropriate for me to be making these decisions. What is really required is that the National Centre for Pharmacoeconomics, NCPE, and the HSE national drugs committee, which is made up of doctors, specialists and persons with the correct economic expertise, make these determinations, and I hope they can in this case, sooner rather than later.